Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
3
×
national blog main
biotech
boston blog main
boston top stories
drugs
accelerated approval
acute hepatic porphyria
alnylam pharmaceuticals
aminolevulinic acid
biobucks
boston
calistoga pharmaceuticals
car-t immunotherapy
checkpoint inhibitors
clinical trials
diagnostics
gilead sciences
givosiran
hatteras venture partners
healthit
idelalisib
immuno-oncology
investing
kite pharma
kymriah
license
medical devices
medicare
national top stories
raleigh-durham
raleigh-durham blog main
raleigh-durham top stories
rna interference
san francisco
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
tango therapeutics
What
far
3
×
drug
million
new
sciences
adding
alnylam
bets
boost
cancer
cash
cleared
committed
data
deploy
expensive
fund
gilead
hatteras
interference
investments
kicking
latest
launches
life
market
medicine
nasdaq
ok
partners
paying
pharmaceuticals
pipeline
plans
program
rna
rnai
science
second
seek
Language
Current search:
far
×
" life sciences "
×
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug